Search research articles
Contact Us
Filters
Showing results (181-190 of 262) with videos related to
Page
of 27
Sort By:
Journal of Substance Abuse Treatment
|
April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence
R B Rothman, D A Gorelick, S J Heishman, et al.
Peptides
|
November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site
R B Rothman, A Mahboubi, V Bykov, et al.
NIDA Research Monograph
|
January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chloride
J A Danks, F C Tortella, V Bykov, et al.
Neuropharmacology
|
May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulation
H Xu, C H Kim, Y C Zhu, et al.
NIDA Research Monograph
|
January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligands
R B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology
|
February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands
R B Rothman, A Reid, A Mahboubi, et al.
Neuropeptides
|
October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro
R B Rothman, V Bykov, A Reid, et al.
European Journal of Pharmacology
|
January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites
R B Rothman, V Bykov, J B Long, et al.
Synapse (New York, N.Y.)
|
November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
R B Rothman, M H Baumann, C M Dersch, et al.
Neurochemical Research
|
September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding
Q Ni, H Xu, J S Partilla, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 262) with videos related to
Sort By:
Page
of 27
Journal of Substance Abuse Treatment
|
April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence
R B Rothman, D A Gorelick, S J Heishman, et al.
Peptides
|
November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site
R B Rothman, A Mahboubi, V Bykov, et al.
NIDA Research Monograph
|
January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chloride
J A Danks, F C Tortella, V Bykov, et al.
Neuropharmacology
|
May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulation
H Xu, C H Kim, Y C Zhu, et al.
NIDA Research Monograph
|
January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligands
R B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology
|
February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands
R B Rothman, A Reid, A Mahboubi, et al.
Neuropeptides
|
October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro
R B Rothman, V Bykov, A Reid, et al.
European Journal of Pharmacology
|
January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites
R B Rothman, V Bykov, J B Long, et al.
Synapse (New York, N.Y.)
|
November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
R B Rothman, M H Baumann, C M Dersch, et al.
Neurochemical Research
|
September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding
Q Ni, H Xu, J S Partilla, et al.
Page
of 27